Tdap vaccine recommendations
Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices recommends routine Tdap (tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine adsorbed) vaccination of adolescents ages 11-12 years. Panel also recommends catch-up program for adolescents who have already received Td booster. FDA recently approved two Tdap vaccines: GlaxoSmithKline's Boostrix and Sanofi-Aventis' Adacel (1"The Pink Sheet" June 20, 2005, p. 28)...
You may also be interested in...
Sanofi-Aventis' postmarketing commitments for Adacel include a 16,000-patient epidemiologic safety surveillance study of the tetanus, diphtheria and acellular pertussis vaccine
Zydus Cadila is to begin testing a three-dose recombinant DNA vaccine candidate in Phase III Indian trials, which might enter late-stage development ahead of Inovio and AnGes. The company promised to provide 100-150 million doses by end of 2021 at the J.P. Morgan Conference, though adherence could be a roadblock.
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.